Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL)

Hematological Oncology

Volumn 24, Issue 2, 2006, Pages 78-85

  Fischer, Lars ^a   Hummel, Michael ^a   Burmeister, Thomas ^a   Schwartz, Stefan ^a   Thiel, Eckhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

EBV; KIR; LGL; Lymphoproliferation; Natural killer

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; LECTIN RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DNA EXTRACTION; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LARGE GRANULAR LYMPHOCYTE; LARGE GRANULAR LYMPHOCYTE LYMPHOPROLIFERATION; LEUKEMIA; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR GENETICS; NATURAL KILLER T CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; DNA; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 33745773447     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.777     Document Type: Article

References (50)

1. Chan WC, Link S, Mawle A, Check I, Brynes RK, Winton EF. Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes. Blood 1986; 68(5): 1142-1153.
2. Zambello R, Trentin L, Ciccone E, et al. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood 1993; 81(9): 2381-2385.
3. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17(12): 3835-3849.
4. Loughran TP, Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82(1): 1-14.
5. Gonzales-Chambers R, Przepiorka D, Winkelstein A, et al. Lymphocyte subsets associated with T cell receptor beta-chain gene rearrangement in patients with rheumatoid arthritis and neutropenia. Arthritis Rheum 1992; 35(5): 516-520.
6. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994; 84(5): 1620-1627.
7. Handgretinger R, Geiselhart A, Moris A, et al. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 1999; 340(4): 278-284.
8. Saunthararajah Y, Molldrem JL, Rivera M, et al. Coincident myelody splastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001; 112(1): 195-200.
9. Oshimi K, Yamada O, Kaneko T, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993; 7(6): 782-788.
10. Neben MA, Morice WG, Tefferi A. Clinical features in T-cell vs. natural killer-cell variants of large granular lymphocyte leukemia. Eur J Haematol 2003; 71(4): 263-265.
11. Mollet L, Fautrel B, Leblond V, et al. Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT. Leukemia 1999; 13(2): 230-240.
12. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP, Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89(1): 256-260.
13. Lamy T, Loughran TP, Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13(4): 230-240.
14. Lanier LL, Kipps TJ, Phillips JH. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J Exp Med 1985; 162(6): 2089-2106.
15. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136(12): 4480-4486.
16. Loughran TP, Jr., Starkebaum G, Aprile JA. Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia. Blood 1988; 71(3): 822-824.
17. Kelly A, Richards SJ, Sivakumaran M, et al. Clonality of CD3 negative large granular lymphocyte proliferations determined by PCR based X-inactivation studies. J Clin Pathol 1994; 47(5): 399-404.
18. Moretta L, Mingari MC, Pende D, Bottino C, Biassoni R, Moretta A. The molecular basis of natural killer (NK) cell recognition and function. J Clin Immunol 1996; 16(5): 243-253.
19. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
20. Colonna M, Nakajima H, Navarro F, Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999; 66(3): 375-381.
21. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19: 197-223.
22. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993; 342(8868): 398-401.
23. Steinhoff M, Hummel M, Anagnostopoulos I, et al. Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin. Blood 2002; 100(2): 578-584.
24. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17(12): 2257-2317.
25. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51(6): 1229-1239.
26. Tefferi A, Greipp PR, Leibson PJ, Thibodeau SN. Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide. Leukemia 1992; 6(5): 477-480.
27. Lima M, Almeida J, Montero AG, et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004; 165(4): 1117-1127.
28. Busque L, Gilliland DG. X-inactivation analysis in the 1990s: promise and potential problems. Leukemia 1998; 12(2): 128-135.
29. Pellenz M, Zambello R, Semenzato G, Loughran TP, Jr. Detection of Epstein-Barr virus by PCR analyses in lymphoproliferative disease of granular lymphocytes. Leuk Lymphoma 1996; 23(3-4): 371-374.
30. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84(1): 51-55.
31. Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004; 18(4): 763-770.
32. Gelb AB, van de RM, Regula DP, Jr., et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 1994; 25(9): 953-960.
33. Shimodaira S, Ishida F, Kobayashi H, Mahbub B, Kawa-Ha K, Kitano K. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage. Br J Haematol 1995; 90(3): 578-584.
34. Chou WC, Chiang IP, Tang JL, et al. Clonal disease of natural killer large granular lymphocytes in Taiwan. Br J Haematol 1998; 103(4): 1124-1128.
35. Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 1983; 131(4): 1789-1796.
36. d'Angeac AD, Monier S, Pilling D, Travaglio-Encinoza A, Reme T, Salmon M. CD57+ T lymphocytes are derived from. Eur J Immunol 1994; 24(7): 1503-1511.
37. Legac E, Autran B, Merle-Beral H, Katlama C, Debre P. CD4 + CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 1992; 79(7): 1746-1753.
38. Cambiaggi A, Orengo AM, Meazza R, et al. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. Blood 1996; 87(6): 2369-2375.
39. Uhrberg M, Valiante NM, Young NT, Lanier LL, Phillips JH, Parham P. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J Immunol 2001; 166(6): 3923-3932.
40. van Bergen J, Thompson A, van der SA, Ottenhoff TH, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 2004; 173(11): 6719-6726.
41. Valiante NM, Uhrberg M, Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7(6): 739-751.
42. Hoffmann T, de Libero G, Colonna M, et al. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol 2000; 110(3): 525-537.
43. Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 2003; 120(6): 1026-1036.
44. Bigouret V, Hoffmann T, Arlettaz L, et al Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 2003; 101(8): 3198-3204.
45. Epling-Burnette PK, Painter JS, Chaurasia P, et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004; 103(9): 3431-3439.
46. Pascal V, Schleinitz N, Brunet C, et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 2004; 34(10): 2930-2940.
47. Mingari MC, Schiavetti F, Ponte M, et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 1996; 93(22): 12433-12438.
48. Huard B, Karlsson L. KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement. Nature 2000; 403(6767): 325-328.
49. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today 1998; 19(4): 153-157.
50. Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004; 172(3): 1455-1462.